Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |